{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06090721",
            "orgStudyIdInfo": {
                "id": "DMT310-009"
            },
            "organization": {
                "fullName": "Dermata Therapeutics",
                "class": "INDUSTRY"
            },
            "briefTitle": "DMT310-009 Topical in the Treatment of Acne Vulgaris",
            "officialTitle": "A PHASE 3 STUDY OF TOLERABILITY, SAFETY, AND EFFICACY, OF DMT310 IN PATIENTS WITH ACNE VULGARIS",
            "therapeuticArea": [
                "Dermatology"
            ],
            "study": "topical-in-the-treatment-of-acne-vulgaris"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-12",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-12-08",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-01-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-03-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-13",
            "studyFirstSubmitQcDate": "2023-10-13",
            "studyFirstPostDateStruct": {
                "date": "2023-10-19",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-12-15",
            "lastUpdatePostDateStruct": {
                "date": "2023-12-21",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Dermata Therapeutics",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The objective is to evaluate the tolerability, safety, and efficacy of DMT310 topical powder mixed with diluent in male and female patients with moderate to severe facial acne vulgaris"
        },
        "conditionsModule": {
            "conditions": [
                "Acne Vulgaris"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 555,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "DMT310 Topical Powder",
                    "type": "EXPERIMENTAL",
                    "description": "DMT310 Powder mixed with Hydrogen Peroxide",
                    "interventionNames": [
                        "Drug: DMT310"
                    ]
                },
                {
                    "label": "Placebo Topical Powder",
                    "type": "EXPERIMENTAL",
                    "description": "Placebo powder mixed with Hydrogen Peroxide",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "DMT310",
                    "description": "Topical Powder",
                    "armGroupLabels": [
                        "DMT310 Topical Powder"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Placebo Topical Powder",
                    "armGroupLabels": [
                        "Placebo Topical Powder"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Efficacy as measured by lesion counts",
                    "description": "Inflammatory and Noninflammatory",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Efficacy as measured by Investigator Global Assessment (IGA)",
                    "description": "0 Clear No evidence of facial acne vulgaris\n\n1. Almost Clear Few non-inflammatory lesions (comedones) are present; a few inflammatory lesions(papules/pustules) may be present; no nodulo-cystic lesions are allowed)\n2. Mild Several to many non-inflammatory lesions (comedones) are present; a few inflammatory lesions (papules/pustules) are present; no nodulo-cystic lesions are allowed\n3. Moderate Many non-inflammatory (comedones) and inflammatory lesions (papules/pustules) are present; no nodulo-cystic lesions are allowed\n4. Severe Significant degree of inflammatory disease; papules/pustules are a predominant feature; a few nodulo-cystic lesions may be present; comedones may be present",
                    "timeFrame": "12 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Incidence of adverse events as a measure of safety and tolerability",
                    "description": "Incidence of adverse events as a measure of safety and tolerability",
                    "timeFrame": "12 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient sex at birth, male or non-pregnant female at least 9 years of age\n* Clinical diagnosis of moderate to severe acne vulgaris as determined by:\n\nInvestigator's Global Assessment (IGA) at Randomization; Patient has at least 20 inflammatory lesions and at least 20 noninflammatory lesions on the face\n\n* Patient is willing to apply the Investigational Product as directed\n* Patient is willing and able to comply with the protocol\n\nExclusion Criteria:\n\n* Patient is pregnant or planning to become pregnant\n* Patient is taking a topical therapy on the face which may affect the patient's acne",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "9 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Dermata Study Director",
                    "role": "CONTACT",
                    "phone": "(858) 223-0883",
                    "email": "clinicaltrial@dermatarx.com"
                }
            ],
            "locations": [
                {
                    "facility": "Center for Dermatology Clinical Research, Inc.",
                    "status": "RECRUITING",
                    "city": "Fremont",
                    "state": "California",
                    "zip": "94538",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Marylu Silva",
                            "role": "CONTACT",
                            "phone": "510-797-0140",
                            "email": "marylus@ctr4derm.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.54827,
                        "lon": -121.98857
                    }
                },
                {
                    "facility": "DermResearch",
                    "status": "RECRUITING",
                    "city": "Austin",
                    "state": "Texas",
                    "zip": "78759",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jennifer Martinez",
                            "role": "CONTACT",
                            "phone": "512-349-9889",
                            "email": "studiesdri@vial.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.26715,
                        "lon": -97.74306
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000152",
                    "term": "Acne Vulgaris"
                }
            ],
            "ancestors": [
                {
                    "id": "D000017486",
                    "term": "Acneiform Eruptions"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000012625",
                    "term": "Sebaceous Gland Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3512",
                    "name": "Acne Vulgaris",
                    "asFound": "Acne Vulgaris",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8219",
                    "name": "Exanthema",
                    "relevance": "LOW"
                },
                {
                    "id": "M19751",
                    "name": "Acneiform Eruptions",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15439",
                    "name": "Sebaceous Gland Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M9918",
                    "name": "Hydrogen Peroxide",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}